Relentless Health Value

Since 2010, under Pablo's leadership, Antidote has raised $26 million in venture capital and grown to become a leading player within the digital health sector, empowering thousands of patients worldwide to discover and access potential new treatment options through clinical trials. Pablo is a seasoned entrepreneur and manager of internet companies. He's been building high-scale businesses in online retail, travel, mobile, media, and now health sectors since the late 1990s, including firms such as NetJuice, DondeComprar.com, Kelkoo (acquired by Yahoo!), Kayak (acquired by Priceline), and ValueClick (acquired by Conversant). Pablo has spoken about technology, health care, and innovation at Harvard Medical School, DIA, Disruptive Innovations, Health 2.0, Digital Health Forum, and many others. He has been included in the "100 Club" by SVC2UK and the "Ones to Watch" list by The Sunday Times's Tech Track 100 and was recently named one of MM&M's Healthcare Transformers of 2018. He's also been featured in Wired, the Financial Times, and Forbes; on CNBC, TechCrunch, and Re/code; and more. Tou can sign up for the Antidote platform by going to antidote.me. You can also learn more by emailing [email protected].

Alex Lickerman, MD is a primary care physician, author, speaker, entrepreneur, and founder of ImagineMD, a direct primary care medical practice headquartered in Chicago. ImagineMD works with self-insured and fully-insured businesses and their benefits consultants to help lower health care costs and improve the access to—and quality of—health care for their employees. This enables businesses to attract and retain top talent, as well as increase productivity and reduce absenteeism—all to increase the value of the business itself. You can learn more about DPC and ImagineMD at www.imaginemd.net.

This podcast inbetweenisode is mostly dedicated to Pharma teams who have determined that EHRs and Health Information Technologies are here to stay, and that it's a business imperative to develop initiatives that suit a digitized health care ecosystem. However, this info also has relevance to startups or other entrepreneurs looking to work with Pharma. Take this as a word of advice... if you are working with a Pharma team and you're noticing that they are not doing the things that I'm going to talk about... get the check up front, if you know what I mean. When not hosting the show, Stacey is co-president of Aventria Health Group, a marketing agency and consultancy. Aventria specializes in helping pharmaceutical, employer, pharmacy, and health system clients improve patient outcomes by creating and leveraging collaborations with other health care organizations. For more than 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and, most of all, the patient. 00:00 Integrating and digitizing in Pharma. 02:00 EHR Strategies—Now what? 02:15 Finding a sufficient process to achieve an EHR strategy. 03:00 The symptoms a team experiences when lacking a process model for EHR-related efforts. 04:30 Symptom #2: The business objective is not a business objective. 08:50 "Technology in itself has no value. Business models have value." 10:00 Four major technology archetypes of customers. 10:25 Stage 3: Solution Construction. 11:10 Technology selection. 14:15 "Pharma tends to be risk averse." 15:20 The answer to choosing the right solution. 16:00 Learn more at aventriahealth.com

I was thinking about this when reading that Forbes article that came out the other day that 44% of Americans skip doctor visits or medical care due to cost. Here's my point: There could be 2 prongs to this. One of them is that the costs are too high. And yep, they are. Even more distressing when you consider that only a dime on every dollar spent on health care goes to the physician or nurse or person actually providing the care. So much is chewed up by invisible middle people adding questionable value to patient care. But here's another prong that you might not have thought of. I remember in one of my marketing classes ages ago the case study about classified ads. Classified ads that listed the price were something like 50% more successful than those that did not. If there's no price, consumers just assume the price is too high. Consumers are consumers whether they're buying a used lawnmower or medical care, and they simply assume the cost is too high when the price tag is turned under. Buying something and being obligated to pay for it even if you don't know what you're getting yourself into... that's a risk that might be a factor in that 44% not bothering to show up for care they need. Today, I speak about the hidden costs and frictions in health care with Joe Murad, President and CEO of PokitDok. Costs and frictions that make being a health care consumer a less than optimal experience. Joe most recently served as Managing Director and Head of Individual Exchange Solutions for Willis Towers Watson where he was responsible for the largest private health insurance exchange. Prior to WTW, Joe was the COO and a founding team member of Extend Health, Inc. from its inception until its $435MM sale to Towers Watson in 2012. Before Extend Health, Joe was part of the initial team at eHealth (IPO: EHTH) where he served as the Director of Business Development and was instrumental in building the company's early overall success. Before eHealth, Joe held numerous market facing roles at Informix Software, Inc. (acquired by IBM in 2001) by way of its acquisition of Illustra Information Technologies in 1995. You can learn more at pokitdok.com

Renya is a Partner in the New York City office of Mercer Health & Benefits and leads the Center for Health Innovation (CHI). CHI is a national team, which includes Mercer LABS, focused on driving market change via collaboration with our clients, our colleagues, and thought leaders across the ecosystem to generate unbiased solutions that translate health innovations into relevant and actionable opportunities for employers. In addition, Renya continues to actively participate and lead consulting engagements that focus on strategic planning, population health management, and health innovation. Prior to joining CHI, Renya served as the Total Health Management Practice Leader for the Central Market where she focused on creating health management and well-being strategies for multinational employers. She led efforts focused on designing high performing care management programs, assessing next generation advocacy models, and developing new approaches to drive optimized health engagement through digital solutions. These projects resulted in industry-leading health outcomes—and more importantly—supported her client's broader workforce goals like optimizing productivity and retaining talent. This work spanned many industries including pharma, manufacturing, technology, and academia. You can learn more at mercer.com.

Dr. Lipi Roy is an internal medicine physician board certified in addiction medicine as well as clinical assistant professor at the NYU School of Medicine, Department of Population Health. She is currently the medical director of an addiction treatment center in New York City. In her previous role as Chief of Addiction Medicine for NYC jails including Rikers Island, Dr. Roy oversaw substance use treatment and recovery efforts for nearly 10,000 incarcerated men and women at the nation's second-largest jail. Previously, she was a primary care doctor to Boston's vulnerable homeless population among whom the leading cause of death was drug overdose. She also served as an attending physician at Massachusetts General Hospital and an instructor of medicine at Harvard Medical School. Dr. Roy completed her medical degree and master's in public health degree at Tulane University in New Orleans, followed by residency training in internal medicine at Duke University Medical Center. Dr. Roy is a strong advocate for public service. In addition to caring for incarcerated and homeless men and women, she has worked with the underserved in Nicaragua and India as well as New Orleans residents affected by Hurricane Katrina. Dr. Roy has also provided medical relief to earthquake victims in Haiti and volunteered in the medical tent at the Boston Marathon. She currently volunteers with the New York City Medical Reserve Corps. You find out more information at lipiroy.com.

Tatyana Kanzaveli has gone from a programmer to senior executive at Big 5 to founder and CEO of a startup company along her 20-year career. She is recognized as a thought leader and mentor for her ability to guide Fortune 500 and startup companies through business challenges. She's worked for major companies like PricewaterhouseCoopers and Fujitsu and startups in the early days of the Web. Tatyana has personally helped companies jump from 0 to millions in revenue, even during the toughest economic times. She has also opened new verticals and markets. Today, she is the founder and CEO of Open Health Network, a startup in a big data/artificial intelligence health care space. She is a mentor at 500Startups and Richard Branson Entrepreneurs Centre and serves on boards for private companies. She also is licensee and organizer of highly notable TEDxBayArea conferences and is a frequent speaker at United States and international conferences on innovation, entrepreneurship and digital health. Tatyana has been featured in the White House blog , spoke at the United Nations, and presented at the first White House Demo Day hosted by President Obama. She was recognized as 1 of the Top 10 Influential Women in Health IT 2015. Tatyana was USSR chess champion an played in the same team with Gary Kasparov. She loves to cook and kayak. You can learn more by emailing [email protected] or by going to www.openhealth.cc

Anne C. Beal, MD, MPH, is dedicated to improving health care in the United States, particularly for vulnerable patient groups. Her career is devoted to providing access to high quality health care and has included delivering health care services, teaching, research, public health, and philanthropy. Dr. Beal is Senior Vice President and Head of Global Patient Solutions for Sanofi, an integrated, global health care company focused on patient needs and engaged in the research, development, manufacturing, and marketing of health care products. In that role, she is supporting a culture of patient-centeredness that ensures patients, their needs and priorities, come first in all of the work of Sanofi. Prior to that, she was the Deputy Executive Director and Chief Engagement Officer for the Patient-Centered Outcomes Research Institute (PCORI) in the US, which was created by the Affordable Care Act to improve health care delivery and outcomes by helping people make informed health care decisions based on research that is guided by patients, caregivers, and the broader health care community. As PCORI's first Chief Officer for Engagement, Dr. Beal was charged with ensuring that the voices of patients and other stakeholders are reflected in their research portfolio. In her role as Deputy Executive Director, she helped to see that PCORI worked efficiently and effectively to carry out its mission as the nation's largest research institute focused on patient-centered outcomes research.

Chief Information Officers (CIOs) are not just "the computer people" anymore. Technology is no longer relegated to the category of operational overhead. Technology is a strategic imperative. It's a competitive differentiator, it's a driver of success in today's connected era, an era increasingly dependent on outcomes-based revenue. On the other hand, when something goes wrong, technology gets blamed even if the real problem is a shabby process or insufficient training. Today, I have a candid conversation with Sue Schade from StarBridge Advisors about the what and how of being a CIO. Sue is the perfect person to have this conversation because she's had the opportunity to serve in the role of CIO or interim CIO at 4 health systems in 4 geographies with 4 different cultures and levels of sophistication and leadership teams. Sue is a Principal at StarBridge Advisors, LLC. A nationally recognized health IT leader, she recently served as interim CIO at Stony Brook Medicine on Long Island and at University Hospitals in Cleveland, Ohio. Prior to joining StarBridge Advisors, she was a founding advisor at Next Wave Health Advisors. Sue has more than 30 years' experience in health care information technology management, and was recognized as the CHIME-HIMSS John E. Gall, Jr. CIO of the Year in 2014. You can learn more at starbridgeadvisors.com or at sueschade.com.

Cyrus Maaghul is a serial entrepreneur currently applying distributed systems, blockchain, and cryptocurrency technology to the health care industry as founder and CEO of HealthCombix and Co-founder/Board Member at PointNurse. Cyrus' health care blockchain thought-leadership has appeared in articles on CoinDesk, Nasdaq, Distributed, and other media outlets. His experience as a payments technology entrepreneur and working inside world-class organizations like Fidelity Investments' Blockchain Incubator and Deloitte Consulting give him a unique perspective to advise, develop strategy, and build decentralized networks. HealthCombix is currently developing new foundational infrastructure and custom applications for decentralized health care, including identity, consent, privacy, smart health trusts, governance, and asset management capabilities. PointNurse is a digital decentralized autonomous-based peer-to-peer virtual health platform seeking to drive down the cost of primary care, streamline clinical trials, and nursing by displacing various intermediaries. Cyrus' interest in blockchain technology began in 2013 after investing in Bitcoin. This led to his investigating how to use blockchain to solve problems related to privacy, peer-to-peer data sharing, security, administration costs, and virtual community governance. You can learn more at healthcombix.com.

Roy is Chief Innovation Officer at Penn Medicine, working to rapidly design, test and implement high impact health care delivery practices. His team crafts interventions to achieve dramatically improved patient outcomes, experience, and high value care. In the past 4 years, they have driven measurable progress in readmission rates, frequent use of the ER, medication adherence, screening rates, antibiotic stewardship, and making a population normotensive, among other advances. Previously, Roy served as the first VP of Innovation for Intuit, a leading software company best known for Quicken and TurboTax. In this role, he led changes in how Intuit managed new business creation, allowing teams to experiment quickly at low cost. Intuit now consistently appears on Forbes' list of the most innovative companies in the world. Prior to leading innovation, Roy's Quicken team achieved record profitability and product leadership while growing to 14 million consumers. Roy's 18 years with Intuit spanned the early years in software to their emergence as a leading SaaS provider. Outside of his Penn role, Roy advises startups and Fortune 100 companies building new technology businesses focused on making a meaningful difference in people's lives. Roy received his MBA from Stanford and graduated with honors from Harvard College. 00:00 Article by Paul Graham "Do Things That Don't Scale." 01:30 Video from Alberto Savoia at Stanford about pretotyping. 02:15 Chris Trimble How Stella Saved the Farm. 03:15 Stories off of University of Penn's Web site, www.pennmedicine.org

Dr. Robert Pearl is the former CEO of the Permanente Medical Group (1999-2017), the nation's largest medical group, and former president of the Mid-Atlantic Permanente Medical Group (2009-2017). In these roles, he led 9,000 physicians, 35,000 staff, and was responsible for the nationally recognized medical care of 4 million Kaiser Permanente members on the west and east coasts. Recently named one of Modern Healthcare's 50 most influential physician leaders, Robert is an advocate for the power of integrated, prepaid, technologically advanced, and physician-led health care delivery. He serves as a clinical professor of plastic surgery at Stanford University School of Medicine and is on the faculty of the Stanford Graduate School of Business, where he teaches courses on strategy and leadership, and lectures on information technology and health care policy. In 2017, he authored Mistreated: Why We think We're Getting Good Health Care—And Why We're Usually Wrong, a Washington Post bestseller that offers a road map for transforming American health care. All proceeds from the book benefit Doctors Without Borders. As a regular contributor to Forbes, Robert covers the business of health care and the culture of medicine. He has been featured on CBS This Morning, CNBC, NPR, and in TIME, USA Today and Bloomberg News. He has published more than 100 articles in various medical journals and contributed to numerous books. He is a frequent keynote speaker at health care and medical technology conferences, Robert has addressed the Commonwealth Club, the World Health Care Congress, and the Institute for Health Care Improvement's National Quality Forum. Board certified in plastic and reconstructive surgery, Robert received his medical degree from the Yale University School of Medicine, followed by a residency in plastic and reconstructive surgery at Stanford University. From 2012 to 2017, he served as chairman of the Council of Accountable Physician Practices (CAPP), which includes the nation's largest and best multispecialty medical groups, and participated in the Bipartisan Congressional Task Force on Delivery System Reform and Health IT in Washington, DC. Stacey Richter is Co-President of Aventria Health Group, a marketing agency specializing in helping pharmaceutical, device, and pharmacy clients gain access to patients by creating and leveraging partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and, most of all, the patient. Alex Akers is Vice President for Business Development with Health Catalyst, a Utah-based, next-generation data, analytics, and decision-support company. He has been with Health Catalyst since 2015. Alex began his career in health care consulting, working for KPMG and Accenture in their health care strategy practices, and then shifting to revenue cycle reengineering with Stockamp & Associates. His passion for technology in health care really took off after he joined Microsoft and was responsible for health care strategy in their payer segment. After a stint with Grand Rounds in San Francisco, Alex landed at Health Catalyst. 00:00 Dr. Robert Pearl, author of Mistreated: Why We think We're Getting Good Health Care—And Why We're Usually Wrong. 01:30 How bad is the problem in American health care? 04:35 How our health system lags in overall health, according to third-party, objective data analysis. 05:20 Rampant overtreatment, and how this adds to the problem. 08:30 How can context improve health care? 09:00 The 4 pillars of improving health care outcomes. 12:40 Integration as a crucial step to maximizing quality. 13:00 Pay-for-value as the second pillar of improving health outcomes. 17:20 Technology as the third pillar. 17:45 How current health care tech being utilized is 50+ years old. 19:30 Why video isn't utilized more in health care, despite being relatively inexpensive. 21:20 Do doctors hate technology? 22:30 "All of medicine is probability." 24:50 "We fail to do the things that we know we should do." 27:00 Physician and clinician-led as the fourth pillar. 28:45 "We don't have a system; we don't have a structure." 29:35 "To do that is going to require leadership." 30:00 Dr. Pearl's advice for actionable change. 31:00 "This is the time to change; don't wait for disruption to occur."

Prior to Aventria, David held several commercial leadership roles, including Head of Oncology Marketing at Genentech and VP Strategic Marketing at Schering AG, specializing in commercializing oncology and specialty products. He was also instrumental in the commercialization of Taxotere, Fludara, Herceptin, and Rituxan. Paul has extensive experience leading successful market access commercialization strategies of specialty pharmaceuticals throughout their life cycles, including several landmark oncology products and other specialty therapeutics. Paul is a former Vice President of Payer Marketing with Bayer and former Vice President and Head of Oncology Managed Markets and Market Access at Novartis Pharmaceuticals. He is an RPh and a graduate of Rutgers University's Ernest Mario College of Pharmacy.

Julie is an executive pharmaceutical leader with over 20 years of experience across all phases of development both on the commercial and research sides of the organization. She leverages her Masters in Business Administration and Doctorate of Pharmacy to develop and deliver strategic patient-centric value propositions to optimize patient access and improve outcomes in patients with difficult to treat diseases leading to longer, healthier, and more productive lives. Her years of experience in global and US payer markets provides Julie with intimate knowledge of the current and evolving payer and market access landscape in the United States and around the globe. She has led the development and execution of several outcomes-based contracts with 3 of the largest national payer organizations in the US. Julie is well published, having authored more than 30 publications in peer-reviewed journals and more than 60 peer-reviewed abstracts presented as posters at major scientific congresses.

Wayne Crandall is the president and CEO of NoteSwift. Crandall's career in technology spans sales, marketing, product management, strategic development, and operations. Prior to joining the NoteSwift team, Crandall was president and CEO of CYA Technologies, and then took over as president of enChoice, which specialized in ECM systems and services, when they purchased CYA. Crandall was a co-founder, executive officer, and senior vice president of sales, marketing, and business development at Nuance Communications and was responsible for growing the company to over $120M following the acquisition of Dragon and SpeechWorks. Before Nuance, he was the European managing director of Xerox Imaging Systems, a wholly owned subsidiary of Xerox Corporation, where he established them as the market leader in document recognition software throughout EMEA and the Pacific Rim. Crandall's other career successes included Kurzweil Computer Products, Philips Information Systems, NV, Lexitron (a division of Raytheon Data Systems), and Savin Business Machines. Crandall is much funnier than this executive summary. He brings humor and wisdom to the team, and the ability to find the right person for every job. He enjoys a healthy lifestyle with his family, puppies, and, of course, the occasional round of golf. You can learn more at www.noteswift.com or send Samantha an email at [email protected].

Moore, is CEO of the health care IT analyst firm, Chilmark Research, which he founded in 2007. Chilmark Research was founded on the simple premise of conducting the best research possible that will ultimately lead to improvements in the quality of care a patient receives. Having spent many years in other industry sectors, Moore has seen the dramatic improvements possible through effective adoption and use of IT and is convinced that the same can occur in health care. A core thesis for Chilmark Research is to help guide the industry in specific subsectors of the health IT landscape by focusing on those technology domains that will be truly transformational to the delivery of care. Current areas of research include: analytics, care management and coordination, interoperability, population health management, engagement, and most recently provider-payer convergence. Prior to founding Chilmark Research, Moore led a diverse worldwide team at Dassault Systèmes, based in Paris. As head of corporate, worldwide industry and market intelligence, he worked with the executive leadership to define key global market opportunities, forecast growth, and develop critical paths to market for its numerous software products. Moore has held a number of other senior positions during his career including: SVP at analyst firm ARC Advisory Group; Research Associate at MIT; VP of Marketing for an analytical instrument company; and policy analyst for the Commonwealth of Massachusetts. An accomplished speaker, Moore has made numerous presentations on current and future IT trends and their impact to markets. Widely quoted in numerous publications, he has also been interviewed by: AMA News, CIO, CNBC, Computerworld, eWeek, Health Data Management, HealthIT News, InformationWeek, Investors Business Daily, US News & World Report, The Washington Post, and The Wall Street Journal. Learn more by going to chilmarkresearch.com and find a free copy of the 2017 Healthcare Analytics Market Trends Report during March!

John Lynn is the founder of the HealthcareScene.com network which currently consists of 10 blogs containing over 11,000 articles with John having written over half of the articles himself. These EMR and health care IT-related articles have been viewed over 18 million times. John also manages HealthcareITCentral.com and HealthcareITToday.com, the leading career Health IT job board and blog. He also organized the first of its kind conference and community focused on marketing to healthcare: HealthITMarketingConference.com. Plus, he just launched Health IT Expo, a conference focused on practical health care IT innovation. John is an advisor to multiple health care IT companies and a highly sought-after keynote speaker. John is deeply involved in social media and, in addition to his blogs, can be found on Twitter: @techguy and @ehrandhit.

Eric Haberichter is the co-founder, chairman & CEO of Access Healthnet. He has more than 25 years of health care, management and entrepreneurial experience as a highly motivated, mission-driven innovator and problem solver focused on improving the delivery and sustainability of health businesses. Early in his career, he worked as a radiation therapist and multi-modality radiographer. For 15 years, he worked within a major Wisconsin-based health care system, and in 2004, left system-based health care to work with independent physicians to develop and manage outpatient imaging and ambulatory surgical centers. In 2006, he co-founded Smart Choice MRI, the first flat-rate, quality-assured MRI provider in America. He has worked closely with employers, brokers, payers, TPAs, and medical practices to lower costs, increase quality and improve patient satisfaction. In 2013, he founded NewAmerica Health Strategies, LLC, a medical business consulting firm dedicated to creating value in health care. He was joined by Jim Kolb and Leslie Kolowith, and their experiences in serving the needs of technology start-ups and national networks aided in more fully developing the concept of Access HealthNet and its proprietary technology solution, The Super Option. Providers, employers, networks, and stakeholders can learn more about Access HealthNet at accesshealthnet.com.

Darren is Chief Executive Officer at Aduro, Inc., a human performance company that delivers habit change programs that empower people and organizations to reach their full potential. He brings a unique outlook to the health care sector, combining his experience with the intricacies of the industry with potential he sees in groundbreaking technologies, human analytics and personalized well-being. With more than 15 years of expertise in demonstrated return on population health, Darren helps companies unlock the power of a happier, healthier, and higher-performing workforce. Prior to founding Aduro, Darren has served as Associate Doctor, Clinic Director and Chief Executive Officer of Clear Chiropractic, a collection of practices in the Puget Sound Area specializing in the Blair Chiropractic Technique. Darren received his Doctor of Chiropractic from Georgia's Life University and currently serves as Chairman of the Board at Clear Chiropractic. Darren spends an increasing amount of time developing new opportunities to bring his purpose-driven approach to the larger community with support for behavior health and nutritional lifestyles. When he's not igniting Aduro's culture at a Friday Fire all-company huddle, he can be found curating crowd-pleasing playlists or traversing down the slopes at his favorite mountain hideaway.

Gary is a disrupter and founder of OM Healthcare, Inc. a health care technology startup established in 2015. He has over 18 years of business development experience and over 13 years of executive-level hospital and health system strategy expertise. Gary is a thought leader in the new frontier of health care technology, innovation, and strategy. Over the years Mr. Frazier's leadership and expertise has been sought after for strategic business planning, financial planning, growth strategy, integrated delivery systems, program development, mergers and acquisitions, and physician alignment. His roles have encompassed the rapid growth of Paladin Healthcare through hospital mergers and acquisitions, most notably a $170M acquisition of 2 Tenet hospitals in Philadelphia, PA. He served as a Principal for Vizient Consulting where he focused on physician/hospital alignment and hospital growth strategies for health systems throughout the United States. He was Vice President of Strategy and Business Development for a flagship 434-bed Dignity Health hospital in Central California where he was responsible for all strategy, growth, marketing, physician alignment, payer relations, and strategic partnerships. Before Dignity Health he managed all business development activities for hospital real estate transactions, expansions, and joint ventures in Arizona, California, and Nevada for Hammes Company Healthcare. A native of Southern California, he earned an undergraduate degree from Cal State Dominguez Hills and an MBA from UC Irvine Paul Merage School of Business. He has served as a board member of the California Hospital Association Political Action Committee (CHPAC), the Bakersfield March of Dimes, and the American Heart Association in Central California, and was Chairman of the Bakersfield Museum of Art. You can learn more at www.omhealthcare.com.

Stacey is co-president/CEO of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. Dave is co-president/CEO of Aventria Health Group and president/CEO of Pinnacle Health Communications. He is a 27-year veteran of managed-markets marketing. After working in consumer marketing with AT&T and health care publishing with Elsevier, Dave made the move to medical advertising and communications at KI Lipton, Inc. Subsequently, he became a cofounder of Pinnacle. Dave is an accomplished strategist, providing innovative customer marketing, access, quality, and health intervention solutions for large clients and has directed the development of numerous industry-leading campaigns in primary care and specialty markets. He has supported clients in disease areas that include oncology (Bristol Myers Squibb [BMS], Novartis, Eisai), virology (BMS, Merck & Co.), pharmacy (American Pharmacists Association, Merck, Novartis), and blood disorders (Novo Nordisk), to name a few. Dave has helped more than 15 clients achieve top rankings in their respective categories. He is also an active member of the Pharmacy Quality Alliance. You can learn more about Aventria Health Group at aventriahealth.com or by emailing [email protected].

Tim Thomas, RPh president, Crystal Clear Rx Mr. Thomas is a graduate of the University of South Carolina College of Pharmacy, and has 38 years' experience as a pharmacist. His management background includes residency training and being a Director of Pharmacy at both a hospital and an HMO. For the last 25 years Mr. Thomas has been involved in managed care pharmacy with expertise in formulary, benefit design, and creating value in the pharmacy benefit. He developed a PBM in the 1990's and has held senior positions within the PBM industry. In 2008 he created Crystal Clear Rx, a pharmacy benefit consulting and research firm that is singularly focused on helping clients realize better value from their pharmacy benefit by providing optics into the PBM contracting process, data analysis, and cost effective solutions. You can learn more at www.crystalclearrx.com.

Juan Pablo founded Babyscripts in 2014 with the vision that internet - enabled medical devices would transform the delivery of pregnancy care. Since 2014, Juan Pablo has been named a Healthcare Transformer by the Startup Health Academy in New York and a Wireless Lifechanger by CTIA for his work in detecting problems in pregnancy faster. Juan Pablo is also the architect of the first "Prenatal Care Moonshot" focused on eliminating preterm birth by 2027 through mobile/digital technology and Babyscripts has been named Champions of Change in Precision Medicine by Barack Obama and the White House. Juan Pablo has raised $8.6 million in venture/angel financing for furthering his vision of a data centric model in prenatal care which includes the recent closure of a Series A of $5.5 million. He has orchestrated large partnerships with General Electric and their Healthymagination initiative and the March of Dimes specifically targeting the elimination of premature birth. He has also led the Babyscripts sales team, closing large hospital deals with more than 13 health systems around the country and successfully signing a co-development deal to build an at-risk product with Aurora Health Care in Wisconsin. Juan Pablo is a frequent speaker on the future of health care. He has spoken at the mHealth Summit on "How to Demonstrate Value in Digital/Mobile Health," at the national HIMSS conference on "Establishing ROI and Forming Partnerships: Digital Health Dating," and at the Bio+Tech conference on "Collaborating for Patient Engagement." He has pitched and won Startup Competitions at SXSW at their Barracuda Bowl and the 1776 Healthcare Challenge Cup. He has also been invited to share his thoughts on podcasts and write op-ed articles on startup fundraising and the future of health care. He was recently interviewed by Medistrategy and wrote "3 Musts for Raising Your First Round" and "Why Disruption in Health IT is like a Tiramisu Cake."

Jennifer E. Miller, PhD, is an Assistant Professor at the NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed. Prior to joining NYU, Dr. Miller was based at Harvard University. Dr. Miller currently serves on NYU's Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB, as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention's (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association's (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 35 articles in publications including Nature Medicine and Health Affairs. She was a Fox News pundit from 2009 to 2012 and remains a news commentator, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR. Dr. Miller's current work explores the ethics and governance of new drugs that are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing. 00:00 EP148: Jennifer E. Miller, PhD, Bioethics International and Creator of the Good Pharma Scorecard. 01:00 The Good Pharma Scorecard rankings for 2017. 01:40 Two 100% transparent pharma companies. 02:20 Two stats that prove that Pharma companies are improving. 03:00 Industry improvements on patient trials. 03:25 Ninety-six percent of all patient trials are available to the public. 03:45 Where there wasn't a significant improvement in disclosure in pharma.

Dr. Kyra Bobinet has five words of advice on engaging people in health: be caring, authentic, and useful. As a national speaker, bestselling author and CEO-founder of engagedIN, a neuroscience behavior design firm, Kyra devotes her life to cracking the code of WHY we engage in our health. Everyday, she and her team use neuroscience to make products and communications more engaging. For this work, Kyra received the 2015 Innovator Award from Harvard where she received her Masters in Public Health. She earned her medical degree at UCSF School of Medicine. Dr. Bobinet is the author of Well Designed Life: 10 Lessons in Brain Science and Design Thinking for a Mindful, Healthy, and Purposeful Life. She has been featured by the Wall Street Journal, New York Times, Huffington Post, ExperienceLife and NPR. She has created health start-ups, blockbuster products, health apps, big data algorithms, and evidence-based programs in mind-body & metabolic medicine. A former executive at a large payer, she has designed large-scale population health management and wellness interventions that yielded ROI for Fortune 500 companies. Dr. Bobinet co-teaches patient engagement and health design with Dr. Larry Chu at Stanford School of Medicine, and studied in BJ Fogg's behavior design lab. When she's not geeking out on neuroscience, you can find her engaged in her 160-acre training center in the Santa Cruz Mountains. You can learn more at engagedin.com and changetrainingcenter.com.

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 The state of health care is fragile. 00:45 Antifragile: Things That Gain from Disorder by Nassim Nicholas 02:20 How easy it is for healthcare systems to break down. 02:40 "You can't domesticate disorder, volatility, or uncertainty." 03:15 The requirements of being an antifragile organization. 03:30 "Does everyone on the team understand the end game?" 04:45 Balancing people and processes. 05:25 "There is always judgement involved." 06:30 Overlap and quality control. 09:10 Allow for small mistakes. 11:45 The need for a feedback group. 14:15 Iatrogenic - relating to an illness caused by medical examination or treatment. 15:20 How rapid scaling slows down the ability to become antifragile. 17:10 Testing if you're doing something for the wrong reasons. 18:00 "What does the healthy business look like?" 18:20 How oligopolies make health care more fragile.

Ross Bjella, MBA is the founder and CEO of Alithias, a patient advocacy and population health analytics company serving self-insured employers, insurance companies, networks, and third party administrators. "Alithias" means "the truth" in Greek and currently has >60,000 lives with access to the platform. Ross has held senior management positions in the health care industry, including pharmaceuticals, biotech, and medical devices. Prior to Alithias, Ross served as the CEO of DDN, a leading business process outsourcer for pharma and biotech companies. Ross still consults with pharma companies about 3PL selection and resolving and supply chain issues from time to time. He has a degree in Biology from the University of Minnesota and a MBA from the University of Southern California. You can learn more at alithias.com or by emailing Ross at [email protected], or following Ross on twitter @rossbjella.

Pramod John is team leader of Vivio Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. The Vivio Health plan solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to Vivio Health, Pramod was founder of Oration PBC (acquired by PokitDok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real-time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world's largest health care company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize health care delivery systems, infrastructure, and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMware. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his PhD in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization, and 3Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. You can learn more at www.viviohealth.com.

Erik serves as a Managing Director in the Accenture Health Client Service Group where he manages a large team of healthcare professionals within the Clinical and Health Management Services team. He serves as the Managing Director for Healthcare Provider Technology Consulting in North America, as well as Accenture's Blockchain lead across the healthcare service line and as a co-lead of Accenture's Value Based Care practice in North America. In his role, he partners with senior client executives to develop and drive healthcare transformation strategies, guide healthcare investment decisions, develop innovation roadmaps for new use of health IT, and build transformation programs in support of population health, care management, value based care, and interoperability initiatives. He also has extensive responsibilities for a diverse portfolio of sales and business development activities at major Accenture healthcare clients and leads a wide range of provider and payer sales opportunities across North America. Erik has worked for over 20 years in healthcare, including senior positions in federal, state, and commercial healthcare programs and initiatives, and served in key leadership roles within the healthcare community. He holds leadership advisory positions within the American Health Information Management Association (AHIMA), the Healthcare Information and Management Systems Society (HIMSS), and the Healthcare Financial Management Association (HFMA), and regularly speaks at industry conferences on trends influencing the healthcare industry. He received a certification as a Certified Professional in Healthcare Information & Management Systems (CHPIMS) in 2009 and became a HIMSS Fellow in 2012. You can learn more at accenture.com.

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other healthcare organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 The largest healthcare payers in the country. 01:45 Asking Patients to be good Healthcare Consumers. 03:30 Labeling Healthcare Consumers. 04:10 "A significant portion of the population does not consider themselves a healthcare consumer." 06:00 Identifying vs. not identifying as a Healthcare Consumer. 07:40 What most marketing behavior is motivated by. 09:10 The need for employers to demand change. 10:15 What to do to build and encourage Healthcare Consumerism. 10:25 Refer to Dave Chase's book, or his interview on our podcast, EP107. 10:50 Our podcast interview with Richard Steinhart, EP149. 11:10 The one type of person who might actually consider themselves a full-time Healthcare Consumer. 15:45 "What do we need to do to help everyone in this country realize that we are Healthcare Consumers?" 16:00 "How can we improve the scales to actually be the agents of change that everyone is depending on?"

Gidi Stein, MD, PhD. A practicing physician, researcher and serial entrepreneur. Co-founder and CEO of MedAware, dedicated to eliminate prescription errors and promote patient safety, using big-data analytics and machine-learning algorithms. Gidi also teaches medicine in Tel Aviv Medical School and treats complex patients in Rabin Medical Center, Israel. You can learn more by visiting medaware.com.

Dhruv Khullar, M.D., M.P.P. is a physician at NewYork-Presbyterian Hospital and a researcher at the Weill Cornell Department of Healthcare Policy and Research. He is also a contributor at the New York Times, where he explores the intersection of medicine, health policy, and economics. He recently worked in the ABC News Medical Unit, helping to curate and communicate evolving health stories, and was previously at the White House Office of Management and Budget (O.M.B.), focusing on Affordable Care Act implementation. Dr. Khullar completed his training in internal medicine at the Massachusetts General Hospital and Harvard Medical School, and earned his medical degree (M.D.) at the Yale School of Medicine. He also received a Masters in Public Policy (M.P.P.) from the Harvard Kennedy School, where he was a fellow at the Center for Public Leadership. His work has appeared in the New England Journal of Medicine, Journal of the American Medical Association (JAMA), New York Times, Washington Post, Wall Street Journal, USA Today, The Atlantic, Slate, and other lay and academic publications. He was recently recognized by LinkedIn as one of the Top 10 Healthcare Professionals Under 35. Thank you to Jim Klus-Salisbury for his help with this episode. @Outcomes_guru ; outcomesguru.blogspot.com You can learn more by following Dhruv's writing in the Well section of the New York Times and The Upshot.

Pramod John is team leader of VIVIO Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. VIVIO Health's solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to VIVIO Health, Pramod was founder of Oration PBC (acquired by Pokitdok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician's office and providing real time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world's largest healthcare company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize healthcare delivery systems, infrastructure and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMWare. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his Ph.D. in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization and 3 Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. You can learn more at www.viviohealth.com.

Ethan Basch, MD talks today about a randomized clinical trial where 766 patients used a web-based system to self-report symptoms, triggering alerts to clinicians. The results were impressive. There are learnings and inspiration in this episode for anyone pursuing better patient outcomes, with special relevance for organizations rolling with a value-based care model. Dr. Ethan Basch is an oncologist and Director of Cancer Outcomes Research at the University of North Carolina. His research group established that up to half of patients' symptom side effects go undetected during cancer treatment and clinical trials, and that patient engagement and questionnaires substantially improve detection. His team determined that integrating web-based patient-reported symptoms into oncology clinical practice improves clinical outcomes and reduces health service utilization. His team created a system for the National Cancer Institute (NCI) to collect patient-reported side effects during cancer trials called the 'PRO-CTCAE.' Dr. Basch is also involved in efforts to bring PROs into comparative effectiveness research, routine care, and quality improvement. He is a member of the U.S. National Cancer Institute's Board of Scientific Advisors, PCORI's Methodology Committee, and is an Associate Editor at JAMA. Dr. Basch will discuss results of a widely cited randomized controlled trial testing a "PRO intervention" in routine cancer care, that was a Plenary session at the ASCO annual cancer meeting and was published in JAMA earlier this year. In this trial, 766 patients receiving routine outpatient chemotherapy for metastatic solid tumors were randomly assigned to self-report 12 common symptoms via the web, or to usual care. Treating physicians received symptom printouts at visits and nurses received email alerts when participants reported severe or worsening symptoms. Overall survival was tabulated based on medical records and Social Security Death Index data, estimated using the Kaplan-Meier method, and compared between arms using a log-rank test and Cox proportional hazards regression adjusting for age, sex, race, education level, and cancer type. Cancer types included genitourinary (32% of patients), gynecologic (23%), breast (19%), and lung cancer (26%). Survival results were assessed after a median follow up of 7 years and 517/766 (67%) of participants had died. Median overall survival in the PRO intervention arm was 5.2 months longer than the control arm (31.2 vs. 26.0 months, p=0.03). These results demonstrate that systematic symptom monitoring during outpatient chemotherapy using web-based patient-reported outcomes confers overall survival benefits. These results are being further explored in a U.S. national implementation trial.

It's rare you read an article about health tech and not see the word "interoperability" at some point, probably more than once. If that were a drinking game, we'd all be really drunk by now. Today I speak with Don Lee, a fellow podcast host about how Health Information Exchanges, otherwise known as HIEs, can assist us in the short term to get our data integration act together. This is a little bit of a reality check— blockchain and more elegant solutions might be coming, but today, right now, we need to meet quality measures. And you can't meet quality measures without having a handle on the trips to the ER, eye exams, and specialist visits that are transpiring outside the four walls of any given provider office. Don is an accomplished Health IT expert with a 20-year track record of driving value with technology. Don began his career as custom software developer and eventually built and lead a team of more than 30 engineers. Later, he was the subject matter expert, product manager and head of sales and marketing for a digital health startup that launched a SaaS-platform focused on administrative simplification in healthcare. Today, Don is President of Glide Health IT, LLC, a consulting firm that helps forward-looking organizations align their Health IT and business strategies. The firm specializes in business and product development with a focus on data aggregation, interop, analytics and quality measurement. Don is also the founder, co-host and Executive Producer of The #HCBiz Show!, a podcast dedicated to unraveling the Business of Healthcare. You can learn more by going to glidehealthit.com or [email protected] or by going to thehcbiz.com to listen to Don's podcast.

I talk with Scott Barclay today. Scott is a partner at Data Collective (DCVC), an early-stage fund that makes venture capital investments in data scientists and entrepreneurs working on hard big data problems. We discuss what it takes for an entrepreneur to succeed in the healthcare ecosystem today, including an essential ingredient: Empathy. Data Collective is a $1bn+ venture capital firm focused on early-stage investing in deep tech and data compute, based in Palo Alto and San Francisco but investing globally. Scott focuses on health and data and leads the firm's practice in Computational Care, envisioning and funding the future of special early-stage teams working on hugely ambitious problems in how health care is provided and applied with data and empathy. Current board or investment roles include Karius, Element. AI, Unity Medical, Enzyme, Medical Informatics, Noteworth, SafelyYou, PatientBank, BlueTalon, InnaMed and Subtle Medical. By background, Scott is a serial angel investor and adviser in health and data start-ups. Scott helped create and scale the first massive digital health platform (Surescripts) and served CVS Health as a GM and innovation leader across the company's health care and retail assets. Previous stints include the Boston Consulting Group, starting a capital markets desk in London for Banc of America Securities, and an MBA from Insead. Scott grew up in rural Virginia and worked many summers in a manufacturing plant, and graduated from the University of Virginia where he was militantly liberal arts and math and science. You can learn more at dcvc.com or by emailing [email protected].

Alex Akers is Vice President for Business Development with HealthCatalyst, a Utah-based, next-generation data, analytics, and decision-support company, committed to being a catalyst for massive, sustained improvements in healthcare outcomes. He has been with HealthCatalyst since 2015, primarily focusing on clients in the southeast. Alex began his career in healthcare consulting, working for KPMG and Accenture in their healthcare strategy practices, and then shifting to revenue cycle reengineering with Stockamp & Associates, where he was a Senior Manager. His passion for technology in healthcare really took off after he joined Microsoft, and was responsible for healthcare strategy in their payer segment, working on projects such as improving care giver collaboration with next generation technology, how to gamify healthcare with Xbox Kinect and consumer engagement. He spent time working with the Microsoft-GE joint venture Caradigm, and worked in sales for their analytics platform. After a stint with a San Francisco company called Grand Rounds, Alex landed at HealthCatalyst, and continues to follow his passion for bringing analytics, evidence, and better care to the US healthcare system. Alex holds a Masters in Business Administration and a Masters in Public Health (Health Policy) from the University of Alabama, Birmingham, and attended Auburn University for his undergraduate degree. He lives in Charlotte, NC with his wife Lauren. You can learn more at HealthCatalyst.com.

Leela Barham is a Health Economist by training with an MSc Health Economics from the University of York and BSc Economics from the University of Nottingham. Leela has over a decade of experience in consulting, working with clients from across the world. Leela focuses on policy and health economic issues from pharmaceutical pricing to Health Technology Assessment and more. Leela has worked with patient organizations, the NHS, a health insurer, think tanks, the pharmaceutical industry, and the medical device industry and has been an expert reviewer for the Department of Health to support on issues on innovation. Leela has also worked for the Royal College of Nursing and NERA Economic Consulting, and has been a member of the Department of Health's External Advisory Group on Payment by Results and the HFMAs Costing Special Interest Group. Leela's work has been published in a number of journals and she also regularly contributes to pharmaceutical industry magazines. She has also been a peer reviewer for journals including the European Journal of Health Economics and The Patient. You can learn more on Leela Barham's Facebook and her blog.

Mike Dendy is Vice Chairman & CEO of Advanced Medical Pricing Solutions (AMPS), an Atlanta, GA-based health care cost management company, serving the self-funded (ERISA) payer community. Since joining the Company in 2005, Mike has overseen all aspects of AMPS management, ranging from sales and marketing, to finance and client relations. AMPS has seen organic growth of over 300% over the last 5 years and has continued to increase its offerings in the health care cost containment space. AMPS clients range in size from those in the Fortune 500 to mid-sized regional employers. Prior to joining AMPS, Mike served as Chairman & CEO of HPS Paradigm Administrators Inc. from 1997 until its subsequent sale in 2004. HPS Paradigm is a health insurance Third-Party Administrator (TPA) serving corporate and government employer groups throughout the United States. During his tenure as CEO, HPS Paradigm experienced strong corporate growth, increasing on average 50% in fee income per year, while achieving industry leading EBITDA margins of over 22%. In 2000, Mike oversaw HPS' business process outsourcing (BPO) relationship with Memorial Hospital of Savannah, Georgia, which at the time was one of Georgia's largest hospital systems. Mike served as Executive Director of Memorial's TPA, HMO, PPO, UR/UM and Case Management services provided for the benefit of Chatham County area employers. From 1992-1997, Mike founded and managed Health Partners Services, Inc. (HPS), a brokerage and consulting firm, which specialized in stop-loss insurance, benefit plan design, provider negotiations, pharmacy benefit management, disease management, predictive analysis, and cost containment. HPS developed community health system plans in a number of southeastern US markets and grew consulting revenues to $600,000 annually. Mike holds 2 master's degrees, from Georgia State University in Business Administration (MBA), and Healthcare Administration (MHA) and bachelor's degrees from the University of Georgia in both Journalism and Psychology. In addition to his graduate and undergraduate achievements, Mike attended executive management programs at Harvard's Business, Public Health, and Law Schools. Mike serves on the Advisory Board for the Robinson College of Business and the School of Healthcare Administration at Georgia State University and is the former Board Chairman for the National Safe Care Campaign. Mike was awarded the School of Health Administration's Healthcare Executive of the Year in 2015. You can learn more at www.advancedpricing.com

Lisa R. Erwin is President of The E2 Group, LLC a managed markets consulting company that specializes in Medicare Part D clinical program strategic and operational expertise with a strong focus on Quality and Star Ratings. She also serves as VP of Clinical Strategies for Aventria/Pinnacle Health Communications, a managed market agency. A common theme of Ms. Erwin's 30-year pharmacy career encompassing long-term care, managed-care and hospital pharmacy has been a focus on improving the quality of medication utilization in the senior population. Most recently, Lisa held the position of Senior Director, Medicare Clinical Quality for Catamaran, a pharmacy benefit manager based in Schaumburg, Illinois. In her role at Catamaran, Lisa directed the company STAR ratings strategy and developed analytic and clinical intervention programs with an emphasis on close health plan client collaboration. She also has served as Pharmacy Director for Medicare Business at Blue Cross Blue Shield of Michigan, a provider of PDP and MAPD offerings. As Vice President, Clinical Operations for Omnicare, Inc., the largest institutional pharmacy provider in the United States, she oversaw the implementation of clinical and health management initiatives which were which were uniquely designed to serve 1.2 million residents of skilled facilities, assisted living and other institutions in 48 states. Erwin is a graduate of the University of Michigan College of Pharmacy and has been credentialed as a Certified Geriatric Pharmacist by the Commission for Certification in Geriatric Pharmacy. She has served as a member of the ASCP Task Force on Medication Therapy Management and the Editorial Advisory Board for The Consultant Pharmacist journal. Lisa held the position of co-chair of Stakeholder Advisory Panel (SAP-B) for the Pharmacy Quality Alliance (PQA) in 2015 and currently is an appointed member of the Measure Update Panel (MUP) for PQA.

In April 2013, Dr. Hunt was appointed CPHO (Chief Population Health Officer [CMO/CMIO]) for St. Vincent's Health Partners, Inc., a Physician Hospital Organization with more than 400 providers, and St. Vincent's Medical Center. Dr. Hunt provides physician leadership and direction for the planning, design and implementation of clinical information systems at St. Vincent's Health Partners, Inc. and oversees quality and utilization for its provider network. Under the leadership of Dr. Hunt, St. Vincent's Health Partners, Inc. was the first organization in the country to become accredited and re-accredited by URAC as a Clinically Integrated Network and is leading the charge in changing the face of healthcare in CT. Currently, working with organizational leaders, Dr. Hunt is engaged to develop information system infrastructure to support a super clinically integrated network. As Chief Executive Officer (2016), he is now focused to develop additional opportunities for medical management with employers and payers, enhance network contracting, and continue to support organizational transformation to value reimbursement. Dr. Hunt joined St. Vincent's Health System (SVHS) as CMIO in August 2014. He is working closely with clinical and information technology associates to transition to ongoing operations after the Cerner EMR implementation. Additionally, Dr. Hunt participates with the Valued Care Alliance [VCA] (a newly formed six hospital consortium in Connecticut in which St. Vincent's Medical Center is a founding member) to establish system-wide population management infrastructure. The VCA has been recognized as a leading advanced network by Connecticut and participates with the Community and Clinical Integration Program, and awarded the Accountable Health Communities (AHC) model grant by CMS. Dr. Michael Hunt, EP133. Defining Attribution. How do you define Fee-for-Service Attribution? How do you align your operations to manage and maximize all sides of your business? "Depending on your business model and how you look at those attributions, you define success."

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device and pharmacy clients by creating partnerships with other health care organizations. For twenty years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 Incrementalism - Worth it? 01:51 "The CEO's Guide to Restoring the American Dream: How to Deliver World-Class Healthcare to Your Employees at Half the Cost," by Dave Chase. 02:25 What would Amazon do differently by building a System of Care? 03:15 Does our conviction about the current Healthcare System stop us from creating something better? 04:15 Divestiture Aversion - Why a Healthcare reboot isn't such a bad idea. 11:00 "What are the ramifications if Amazon enters more deeply into that hybrid online-inperson space?" 12:45 How did we get where we are now? - Check out INBW13, INBW12, INBW10. 13:00 Only three stakeholders that have an invested interest in keeping Healthcare Value high: Employers, Taxpayers, and Consumers. 13:20 Large Employers as the only stakeholder with the power to make change in Healthcare. 16:50 Who is going to be behind such a reboot? 19:00 How onsite clinics might be the future and greatly benefit reducing healthcare costs. 20:00 The divorce of patient care and industry needs. 21:50 "Employers don't just have skin in the game, they have entire bodyparts." 22:50 "Employers have a larger call; healthcare is a means to an end for them."

Mr. Steinhart has had a distinguished career as an entrepreneur, investor and executive in the healthcare industry. He has been instrumental in starting or investing in many technology-based companies, several of which have developed products that have become the standard of care in their respective markets. Currently Mr. Steinhart sits on the Board of Directors of Actinium Pharmaceuticals, Inc., a New York-based biopharmaceutical company developing innovative targeted therapies for patients with cancers lacking effective treatment options. Mr. Steinhart is also a member of the Board of Directors of Atossa Genetics, a clinical-stage Seattle-based drug- company that is developing novel, proprietary therapeutics and delivery methods for breast cancer and other breast conditions. Earlier in his career Mr. Steinhart was the Sr. Vice President and CFO at MELA Sciences, a company that received FDA approval for and marketed the world's only non-invasive Melanoma detector. Prior to MELA Sciences, he was a General Partner and CFO at CW Group, Inc., the country's first venture capital firm focused solely on medical technology and biopharmaceutical companies. Mr. Steinhart has also had significant experience in municipal government. He introduced the first mandatory Health Saving Account (HSA) insurance coverage for municipal works in the state of Connecticut. By working with union representatives and insurance company executives, Mr. Steinhart was able to craft a program that delivered high quality affordable healthcare benefits to union workers, while at the same time saving his local municipality millions of dollars in premiums. This program has been widely emulated by many of the 169 towns and cities in Connecticut. Mr. Steinhart currently live in Ridgefield Connecticut with his wife and two sons. He can be reached by e-mail at [email protected]

Jennifer E. Miller, PhD, is an Assistant Professor at the NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed. Prior to joining NYU, Dr. Miller was based at Harvard University. Dr. Miller currently serves on NYU's Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB, as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention's (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association's (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 35 publications, including for Nature Medicine and Health Affairs. She was a Fox News pundit from 2009 to 2012 and remains a news commentator, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR. Dr. Miller's current work explores the ethics and governance of new drugs that are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing. You can learn more at www.bioethicsinternational.org and view the Good Pharma Scorecard.

Founder and CEO of Fit4D, David Weingard David is a diabetes patient who was diagnosed with Type 1 diabetes at the age of 36 while training for a survival race. A veteran of numerous running and triathlon races (including Ironman triathlons consisting of a 2.4M swim, 112M bike and 26.2M run), David committed to rebuild his life and provide positive energy to the diabetes community while coping with the condition on a 24/7 basis. Beginning with shorter races, he gradually learned how to successfully race triathlons with diabetes and within a year, completed the famous Escape from Alcatraz Triathlon in San Francisco Bay. He then began racing Ironman triathlons again – though this time, working through the delicate balance between insulin, food, nutrition and exercise. Through these races, David has fundraised extensively on behalf of the Juvenile diabetes Research Foundation's (JDRF) New York City Chapter. David's personal experience receiving meaningful education and support from a Certified Diabetes Educator (CDE) sparked the idea for Fit4D to leverage technology to scale the patient reach of adherence and outcome improvement programs for pharmaceutical, payer and provider organizations. In 2008, David left Microsoft to found Fit4D, building on his career as an executive in the technology sector. As the founder and CEO of Fit4D, David received the PM360 Elite Entrepreneur award for transforming the diabetes landscape. Under David's leadership PM360 also named Fit4D one of the top innovative healthcare startups in 2015, while ePharma named Fit4D its 2016 audience winner of the Disruptive Technology Showcase and Innovations Challenge. David is transforming the diabetes landscape and improving people's health in the real world every day. David was selected as the Keynote Speaker for the American Diabetes Association's largest fundraising event, Step Out: Walk to Stop Diabetes, 2016. David has given back to the diabetes community by coaching the JDRF Ride to Cure Diabetes and the American Diabetes Association's Tour De Cure many times, and gives back to the entrepreneur community by guiding emerging health technology founders. As a chosen finalist for the Novo Nordisk-Lyfebulb Patient Entrepreneur award, David participated in a panel on patient-centric innovation, sharing his message of hope to an international audience. Most recently, David was the recipient of the first-ever Kate Granger Compassionate Care Award, spotlighting individual contributions to high-tech/high-touch care and awarded to those who demonstrate compassionate care in this area. You can find out more at www.fit4d.com or email [email protected]

Tom Kottler is co-founder and Chief Executive Officer of HealthPrize Technologies, which uses gamification, behavioral economics and consumer marketing concepts to engage and motivate patients. HealthPrize works with top and emerging life science companies to inspire patient loyalty, maximize medication adherence and improve health literacy. Kottler has led multiple high-growth organizations during his career, including Advanced BioHealing, which was acquired by Shire for $750 million, and MedAptus, an innovative healthcare IT company based in Boston, Mass. You can learn more at www.healthprize.com

Andrew Schorr is a medical journalist who was diagnosed with chronic lymphocytic leukemia (CLL) in 1996 and has remained in remission since then. He is the founder of HealthTalk.com, PatientPower.info and PatientPower.eu. He is board chair of the Patient Empowerment Foundation in Europe. He is also the author of The Web-Savvy Patient: An Insider's Guide to Navigating the Internet When Facing Medical Crisis, which was published in 2011. Andrew is a graduate of UNC-Chapel Hill and holds a master's degree in journalism from Columbia University.

Julie is an executive pharmaceutical leader with over 20 years of experience across all phases of development both on the commercial and research sides of the organization. She leverages her Masters in Business Administration and Doctorate of Pharmacy to develop and deliver strategic patient-centric value propositions to optimize patient access and improve outcomes in patients with difficult to treat diseases leading to longer, healthier, and more productive lives. Her years of experience in global and US payer markets provides Julie with intimate knowledge of the current and evolving payer and market access landscape in the US and around the globe. She has led the development and execution of several outcomes-based contracts with 3 of the largest national payer organizations in the US. Dr. Locklear is well published, having authored >30 publications in peer-reviewed journals and >60 peer-reviewed abstracts presented as posters at major scientific congresses.

Dr. Nick is a leader in Digital Healthcare and Innovation, and former Chief Medical Officer for Dell. He provides strategic insights and guidance to support healthcare organizations, medical professionals and patients through information-enabled healthcare. He brings an incremental approach to developing successful strategies and applying technology to achieve a technology environment that is interconnected, efficient and patient-focused. He is a highly sought out speaker on the practical and futuristic use of healthcare technology and how it can improve patient engagement and wellness. Dr. Terheyden brings a distinctive blend of medical practitioner and business strategist, both national and international, to the realm of digital healthcare technology. A graduate of the Royal Free Hospital School of Medicine, University of London, Dr. van Terheyden is a pioneering creator in the evolution of healthcare technology. After several years as a medical practitioner in London and Australia, he joined an international who's who in healthcare, academia and business, in the development of the first electronic health record in the early 1990's and later, as a business leader in one of the first speech recognition companies. His rare combination of patience, creativity, skill and intrinsic business ethics has led him to a diverse career in healthcare with some of the most prestigious hospitals, consulting firms, and technology companies. His focus is on small improvements we can learn from other industries and can be applied in healthcare to bring immediate value, but that also add up to the big leap we need and are all looking for - focusing on evolution not revolution. His most recent position was Chief Medical Officer for Dell where he was responsible for providing strategic insight establishing the organization as an innovator in healthcare technology and Digital Health. In addition to writing and lecturing on futuristic trends in healthcare technology, his advice and counsel is sought by hospitals, physicians and other allied healthcare professionals all of whom are trying to figure out how to integrate and use technology to make the healthcare system work from the perspectives of quality and financial success. Dr. van Terheyden pays attention not just to processes and systems, but to people. His ability to speak in terms people can actually understand makes him a sought-out speaker. Specialties: Digital Health, Internet of Medical Things (IoT), Medical Home, Healthcare Informatics, Speech Recognition, Natural Language Processing, Mobile Health, Social Media.